Largest worldwide study on eczema
Scientists from the Helmholtz Zentrum München and the Cluster of Excellence "Inflammation at Interfaces" in Kiel in collaboration with researchers and clinicians from 14 different countries have...
Monthly Archives: October 2015
Number of moles on right arm could predict risk of deadly skin cancer
Researchers suggests the risk of melanoma skin cancer may be predicted by the number of moles a person has on their right arm - a finding they say could be useful for doctors.
New ‘artificial skin’ steps toward touch feedback for artificial limbs
The ability for prosthetic limbs to sense touch comes within reach, as researchers present their creation of a plastic material that recognizes pressure and sends brain signals.
A novel and effective hyperthermia method for Schistosomiasis japonica prevention and treatment
Schistosomiasis or bilharzia, is a common parasitic disease which can cause bladder dysfunction and hematuria, and even correlate with bladder cancer and increase HIV susceptibility with urogenital...
Psoriasis: one year data from Phase III study evaluating oral Otezla (apremilast) or injectable etanercept versus placebo
Celgene International Sàrl, a wholly owned subsidiary of Celgene Corporation, has announced that results from its ongoing phase III LIBERATE™ trial evaluating Otezla® (apremilast), the...
Avita Medical provides update on ReCell success in treating burn victims in Taiwan
Avita Medical Ltd., a regenerative medicine company specializing in the treatment of wounds and skin defects, today announced that doctors in Taiwan have reported positive results from using...
Always the sun? Other factors might increase the risk of melanoma
UV is the most prominent risk factor associated with melanoma. About 65% of melanomas worldwide can be attributed to UVR exposure - but what about the other 35%?
“The problem of resistance: sexually transmitted infections are becoming more difficult to control”
Almost 400,000,000 people worldwide aged 15-49 years acquire one of four sexually transmitted infections (STIs) each year, as Prof.
Investigational biologic cleared skin better, faster and for longer than ustekinumab in Phase II psoriasis study
New results from a Phase II head-to-head psoriasis study showed superior efficacy of Boehringer Ingelheim's investigational biologic compound BI 655066*, over ustekinumab.
“Tattoo inks: We need a uniform European standard to protect consumers!”
Body adornment is a human characteristic and has been practiced since ancient times in all races and in all continents.